Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...

Patients with vitiligo who received long-term NBUVB phototherapy vs no phototherapy were associated with reduced risks for cardiometabolic diseases.

However, this is not about the gut per se; this is about the role of gut-friendly bacteria in the process of re-pigmentation, particularly in persons with vitiligo. Vitiligo is a chronic ...

Recent network meta-analyses identified the relative outcomes of various vitiligo monotherapies on vitiligo at 6 months.

The specialist paramedical process of vitiligo micropigmentation is different from conventional tattooing. Even though all methods entail applying pigment to the skin, the main distinctions are ...

Vitiligo can inflict profound psychological damage on patients. A series of talks held in the Pavilion gives visitors the opportunity to engage directly with individuals’ experiences.

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...

So, that's exciting news. The anifrolumab trial is moving along nicely. And so we might know soon, whether or not we might have an anti-interferon agent available for the treatment of lupus nephritis.

Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and full ...